Replies to post #439455 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

ha, thanks again

sounds like a small inconsequential addition or subtraction to the overall potential market

but the redefinition definitely helps the data

[newman2021]

The way I huff at it is exclusion gives more efficacy standpoint to DcVaxL as it treats GBM, more specifically mesenchymals. Insurance will pay more, imo.